# US Piriformis Syndrome Market

> US Piriformis Syndrome Market Research Report By Cause (Trauma, Spasms, Others) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.63%
- **2024:** $ 0.06 Million
- **2025:** $ 0.06 Million
- **2035:** $ 0.11 Million
- **Key Players:** Medtronic (US), Johnson & Johnson (US), Stryker (US), Boston Scientific (US), Abbott Laboratories (US), Baxter International (US), Smith & Nephew (GB), Zimmer Biomet (US), NuVasive (US)

**Report ID:** MRFR/Pharma/18467-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** July 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-piriformis-syndrome-market-20014

---

## Market Summary

## **US Piriformis Syndrome Market Overview**

As per MRFR analysis, the US Piriformis Syndrome Market Size was estimated at 38.57 (USD Million) in 2023. The US Piriformis Syndrome Market Industry is expected to grow from 41.5(USD Million) in 2024 to 73 (USD Million) by 2035. The US Piriformis Syndrome Market CAGR (growth rate) is expected to be around 5.268% during the forecast period (2025 - 2035).

### **Key US Piriformis Syndrome Market Trends Highlighted**

The US Piriformis Syndrome Market is witnessing significant trends driven by an increasing prevalence of this neuromuscular condition. Growing awareness about this syndrome among healthcare professionals and patients is a key driver. Initiatives aimed at educating both neurologists and physiotherapists about effective diagnosis and treatment options are on the rise, leading to improved patient outcomes and greater access to specialized care.

Additionally, the national focus on pain management has resulted in more patients being diagnosed, as the healthcare system recognizes the need for addressing chronic pain conditions. There are notable opportunities within the US market that can be explored, particularly in the realm of advanced treatment modalities. Non-invasive therapies such as physical therapy and acupuncture are gaining traction as patients seek alternatives to surgery.

Furthermore, an increase in research funding for alternative treatments, driven by a broader acceptance of complementary medicine, stands to benefit individuals suffering from Piriformis Syndrome. The integration of telehealth services also presents a chance to reach more patients in remote areas, enhancing accessibility to expert care. Recent times have seen a growing trend of personalized medicine in the US healthcare landscape.

After realizing that one-size-fits-all approaches do not deliver optimal results, medical professionals are focusing on tailoring treatment plans based on the specific needs of the individual. This shift toward personalized approaches, combined with the development of new technologies for better diagnosis and treatment options, positions the US Piriformis Syndrome Market for focused growth. As healthcare policies continue to evolve and more emphasis is placed on holistic treatment, the market is likely to undergo further innovations and positive development.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Piriformis Syndrome Market Drivers**

### **Increasing Awareness and Diagnosis of Piriformis Syndrome**

In the United States, there has been a notable increase in awareness and diagnosis of Piriformis Syndrome, leading to more patients seeking treatment. According to the American Academy of Orthopaedic Surgeons, the understanding of musculoskeletal disorders has improved significantly over the past decade. This increase in awareness can be linked to educational programs and diagnostic advancements introduced by organizations like the American Physical Therapy Association, which reported that musculoskeletal pain affects over 50% of adults in the US at some point in their lives.

This growing recognition of Piriformis Syndrome has led to increased patient referrals, contributing to the growth of the US [Piriformis Syndrome Market](../../../reports/piriformis-syndrome-market-6249) Industry as healthcare providers are now more capable of diagnosing patients accurately. Consequently, as more patients are identified and treated, demand for specific therapies related to Piriformis Syndrome treatment continues to rise.

### **Growth in Physical Therapy and Non-invasive Treatment Options**

There is a significant increase in the adoption of physical therapy and non-invasive treatment options for managing Piriformis Syndrome in the United States. The Bureau of Labor Statistics projects that the employment of physical therapists will grow by 22% from 2020 to 2030, much faster than the average for all occupations. This surge in job growth indicates a broader acceptance and utilization of physical therapy services as a primary treatment modality, which can help alleviate symptoms of Piriformis Syndrome.

With organizations like the American Physical Therapy Association promoting evidence-based practice, patients are becoming more aware of the efficacy of physical therapy, driving growth in the US Piriformis Syndrome Market Industry. Non-invasive treatments such as stretching, strengthening exercises, and manual therapy have also gained traction, leading to a healthier population and reduced reliance on surgical interventions.

### **Increased Prevalence of Sedentary Lifestyles**

The prevalence of sedentary lifestyles in the United States has led to an increase in musculoskeletal disorders, including Piriformis Syndrome. According to the Centers for Disease Control and Prevention, over 80% of US adults do not meet the recommended guidelines for physical activity. This trend of prolonged sitting and lack of movement has resulted in a higher incidence of conditions like Piriformis Syndrome.

Consequently, healthcare providers are witnessing more cases, resulting in a growing demand for specialized treatments, thus driving the US Piriformis Syndrome Market Industry. With the increasing focus on workplace ergonomics and wellness programs, more individuals are recognizing the importance of addressing musculoskeletal health, further contributing to market growth.

## **US Piriformis Syndrome Market Segment Insights**

### **Piriformis Syndrome Market Cause Insights**

The US Piriformis Syndrome Market is significantly influenced by the underlying causes of the condition, which can be classified into categories such as Trauma, Spasms, and Others. Trauma plays a crucial role in the onset of Piriformis Syndrome, as injuries from accidents or sports can lead to inflammation or irritation of the piriformis muscle, often resulting in nerve compression. This category is critical because the impact of trauma-related causes can be substantial, leading to both acute and chronic pain, which contributes to the prevalence of this syndrome in the United States.

Spasms, another prominent cause, occur when the piriformis muscle tightens involuntarily. This tightening can lead to pain that radiates down the leg, mimicking sciatica. The prevalence of muscle spasms is significant among patients who engage in repetitive activities or maintain poor posture, making it an area of concern for various occupational health environments in the US. The awareness of these spasms is important for the development of targeted therapies and rehabilitation approaches.

The "Others" category encompasses a range of potential causes, such as anatomical variations, overuse injuries, and other underlying health conditions. These broader causes expand the understanding of the syndrome's complexity and highlight the need for a multifaceted approach to diagnosis and treatment. This diversity within the market segmentation allows healthcare providers to tailor individual treatment regimens, ultimately offering a more personalized healthcare experience.

The complexity of Piriformis Syndrome driven by these causes emphasizes the potential for growth in the US Piriformis Syndrome Market. As medical practitioners and researchers continue to explore the mechanisms behind trauma and muscle spasms, they will likely develop innovative treatment options and therapy methods. Furthermore, the growing awareness among patients regarding the impact of lifestyle factors on muscle health underlines the market's potential to expand in preventive healthcare solutions. The interplay of these causes contributes to the broader dynamics of market growth, influenced by both innovations in treatment and an increasing demand for effective care.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Piriformis Syndrome Market Key Players and Competitive Insights**

The US Piriformis Syndrome Market is characterized by a competitive landscape that includes several key players and a variety of treatment options aimed at alleviating the condition's symptoms, which are often debilitating for affected individuals. Piriformis syndrome occurs when the piriformis muscle compresses the sciatic nerve, leading to pain and discomfort. The treatments in this market range from physical therapy and medication to surgical interventions, each catering to different severity levels of the syndrome.

As a result, competition within the market has intensified, with companies striving to innovate and differentiate their offerings, all while addressing the growing need for effective solutions. Insights into the competitive dynamics reveal particular strengths, market strategies, and geographical emphases employed by leading firms in the sector. Teleflex has carved a niche within the US Piriformis Syndrome market through its robust product offerings that primarily focus on minimally invasive surgical solutions and advanced medical devices.

The company's commitment to innovation is evident in its development of specialized instruments designed to facilitate effective treatment through less invasive means, thereby enhancing patient recovery times and outcomes. Furthermore, Teleflex's strong distribution channels and partnerships with healthcare providers bolster its presence in the market. Their ability to swiftly adapt to technological advancements and clinical feedback allows Teleflex to maintain its competitive edge, ensuring they cater specifically to the needs of practitioners and patients dealing with piriformis syndrome.

Smith and Nephew represents another formidable player in the US Piriformis Syndrome market, offering a wide range of products, particularly in orthopedic solutions and rehabilitation technologies. The company's strength lies in its ability to provide comprehensive treatment options designed to alleviate the symptoms associated with piriformis syndrome, including surgical solutions and post-operative care products. Smith and Nephew’s commitment to research and development has led to successful innovation and the introduction of new technologies aimed at improving patient outcomes. 

Additionally, strategic mergers and acquisitions have enhanced their market position, allowing them to expand their product portfolio and distribution networks within the US. With a focus on advanced surgical techniques and effective rehabilitation products, Smith and Nephew continues to assert its dominance in addressing the challenges presented by piriformis syndrome.

### **Key Companies in the US Piriformis Syndrome Market Include**

## **US Piriformis Syndrome Market Industry Developments**

The US Piriformis Syndrome Market has seen notable developments in recent months, focusing on growth and innovation from key players such as Teleflex, Smith and Nephew, Amedica Corporation, and Medtronic. In particular, there's been increasing interest in minimally invasive procedures and advancements in treatment solutions aimed at alleviating the symptoms of piriformis syndrome. Current affairs highlight a rise in the market valuation of companies like Boston Scientific and Abbott Laboratories, reflecting their commitment to Research and Development, which is positively impacting patient outcomes.

In September 2023, Johnson and Johnson announced a strategic partnership with Aesculap to enhance the availability of their products targeted at treating musculoskeletal disorders, further solidifying their presence in this niche market. Moreover, the ongoing regulatory approvals for innovative devices and medications signify a robust growth trajectory. In the last couple of years, improvements in reimbursement policies for treatment options have played a crucial role in market expansion, driving competitive dynamics among companies like Stryker and NuVasive. Overall, the market's landscape is evolving, supported by technological advancements and strategic collaborations among leading entities.

## **US Piriformis Syndrome Market Segmentation Insights**

### **Piriformis Syndrome Market Cause Outlook**

## Market Drivers

### Technological Innovations in Treatment

Technological advancements in treatment modalities are significantly influencing the piriformis syndrome market. Innovations such as minimally invasive surgical techniques, advanced imaging technologies, and novel therapeutic devices are enhancing the diagnosis and management of this condition. For instance, the introduction of ultrasound-guided injections has improved the accuracy of treatment delivery, leading to better patient outcomes. The market for these technologies is projected to grow, with estimates suggesting a compound annual growth rate (CAGR) of around 7% over the next few years. As healthcare providers adopt these advanced technologies, the efficiency and effectiveness of treatment for piriformis syndrome are likely to improve, thereby driving market expansion. Furthermore, the integration of telemedicine in patient management may also play a role in increasing access to care, further stimulating the piriformis syndrome market.

### Increased Investment in Pain Management

The growing focus on pain management strategies is a significant driver for the piriformis syndrome market. With chronic pain conditions affecting millions of Americans, there is a heightened demand for effective pain relief solutions. The US pain management market is projected to reach approximately $100 billion by 2026, indicating a substantial opportunity for the piriformis syndrome market. This investment is likely to lead to the development of new therapies and treatment protocols specifically targeting piriformis syndrome. Additionally, the emphasis on multidisciplinary approaches, including physical therapy, medication, and alternative therapies, may enhance patient outcomes and satisfaction. As healthcare systems prioritize pain management, the piriformis syndrome market is expected to benefit from increased funding and research initiatives aimed at improving treatment options.

### Growing Incidence of Piriformis Syndrome

The rising incidence of piriformis syndrome in the US is a crucial driver for the piriformis syndrome market. Factors such as sedentary lifestyles, increased participation in sports, and the aging population contribute to this trend. According to recent health statistics, approximately 5-10% of individuals with sciatica may have piriformis syndrome as the underlying cause. This growing prevalence necessitates enhanced diagnostic and therapeutic options, thereby expanding the market. As healthcare providers become more aware of this condition, the demand for effective treatments is likely to increase, leading to a more robust market environment. The increasing number of patients seeking relief from symptoms such as pain and discomfort further fuels the growth of the piriformis syndrome market, indicating a need for innovative solutions and comprehensive care strategies.

### Rising Demand for Non-Invasive Treatments

The shift towards non-invasive treatment options is becoming increasingly prominent in the piriformis syndrome market. Patients are often seeking alternatives to surgery due to concerns about recovery time and potential complications. Non-invasive therapies, such as physical therapy, chiropractic care, and acupuncture, are gaining traction as effective management strategies for piriformis syndrome. Market Research Future indicates that non-invasive treatment modalities are expected to grow at a CAGR of around 6% over the next five years. This trend reflects a broader movement within the healthcare industry towards conservative management approaches, which may lead to a more favorable market environment for non-invasive solutions. As patients become more informed about their treatment options, the demand for these therapies is likely to rise, further propelling the growth of the piriformis syndrome market.

### Enhanced Patient Education and Support Programs

The development of patient education and support programs is emerging as a vital driver for the piriformis syndrome market. As awareness of piriformis syndrome increases, healthcare providers are recognizing the importance of educating patients about their condition and available treatment options. Programs that provide information on self-management techniques, lifestyle modifications, and rehabilitation exercises are becoming more prevalent. This focus on education not only empowers patients but also encourages adherence to treatment plans, potentially leading to better outcomes. The market for educational resources and support services is expected to expand, with estimates suggesting a growth rate of approximately 5% annually. By fostering a more informed patient population, these initiatives may contribute to the overall growth and sustainability of the piriformis syndrome market.

## Future Outlook

The [Piriformis Syndrome Market](https://www.marketresearchfuture.com/reports/piriformis-syndrome-market-6249) is projected to grow at a 6.63% CAGR from 2025 to 2035, driven by increasing awareness and advancements in treatment options.

**New opportunities:**

- Development of telehealth platforms for remote consultations and follow-ups. Investment in innovative physical therapy devices targeting piriformis syndrome. Expansion of educational programs for healthcare professionals on diagnosis and management.

By 2035, the market is expected to achieve substantial growth, reflecting evolving treatment paradigms.

## Segment Insights

### By Cause: Trauma (Largest) vs. Spasms (Fastest-Growing)

The US piriformis syndrome market exhibits a diverse distribution of causes contributing to the condition. Trauma remains the largest cause, driven primarily by accidents and injuries that affect the muscular and skeletal systems. Spasms also account for a significant portion of cases, attributed to muscle contractions that can arise from stress, overexertion, or improper posture. Other causes, including overuse injuries and various unspecified factors, continue to play a role, although they represent smaller shares in the overall market. In terms of growth trends, the segments are responding to broader health awareness and increased physical activity levels among the population. As people engage more in sports and fitness, the incidence of overuse injuries is expected to rise, making it an emerging focus within the market. Additionally, increasing recognition of muscle spasms as a common precursor to piriformis syndrome indicates potential for growth in therapies targeting this cause, reinforcing the dynamic nature of the market as it adapts to changing health trends.

Trauma (Dominant) vs. Spasms (Emerging)

Trauma has established itself as the dominant cause within the US piriformis syndrome market, often requiring immediate medical intervention and long-term rehabilitation strategies. It typically involves acute incidents that can lead to significant pain and discomfort, prompting patients to seek treatment. Conversely, spasms represent an emerging segment, driven largely by lifestyle factors such as prolonged sitting, stress, and fitness-related strains. This segment is gaining traction as awareness increases regarding its role in the development of piriformis syndrome. Market players are beginning to explore innovative treatment options that prioritize addressing muscular stability and flexibility, providing a potential growth avenue as more individuals seek effective management solutions.

### By Diagnostic Test: Magnetic Resonance Imaging (MRI) (Largest) vs. Electromyography (EMG) (Fastest-Growing)

The diagnostic test segment in the US piriformis syndrome market showcases a diverse distribution of methodologies. Magnetic Resonance Imaging (MRI) holds the largest share due to its non-invasive nature and ability to provide detailed images of soft tissues, which is crucial for accurate diagnosis. Computed Tomography (CT) and X-rays also play significant roles, although they are more commonly used for bone assessment. Neurophysiologic Testing and specialized tests like the Beatty Test and FAIR Test indicate a smaller but essential part of the diagnostic landscape in addressing piriformis syndrome. Growth trends within the diagnostic test segment reflect an increasing reliance on advanced imaging techniques and neurophysiologic evaluations. The rise in MRI usage is driven by advancements in technology that enhance image clarity and diagnostics accuracy. Furthermore, Electromyography (EMG) has emerged as the fastest-growing modality, increasingly favored for assessing muscle and nerve function, which is critical for understanding piriformis syndrome dynamics. Facilities are now investing in better diagnostic tools to meet the expected rise in demand for precise evaluations.

MRI (Dominant) vs. EMG (Emerging)

Magnetic Resonance Imaging (MRI) is recognized as the dominant diagnostic tool in the US piriformis syndrome market due to its ability to deliver high-resolution images and its safety profile. It allows healthcare professionals to visualize the anatomy and potential abnormalities of the piriformis muscle and surrounding tissues. In contrast, Electromyography (EMG) represents an emerging trend within this arena, focusing on assessing muscle response to nerve stimulation. As a rapidly evolving diagnostic method, EMG is growing in popularity due to its effectiveness in identifying conditions related to nerve compression and injury, which are pivotal in the evaluation of piriformis syndrome.

### By Treatment: Medication (Largest) vs. Physical Therapy (Fastest-Growing)

In the US piriformis syndrome market, the treatment segment is highly diverse, with medication holding the largest market share. Medications such as NSAIDs and muscle relaxants are commonly used, contributing significantly to the treatment landscape. Following medication, physical therapy is a prominent option, favored for its holistic approach that focuses on strengthening and flexibility. Other treatments like acupuncture and surgery are less common but play essential roles in specific cases. The growth trends in this segment reveal an increasing recognition of non-invasive treatments. Physical therapy is the fastest-growing segment due to heightened awareness of its benefits and rising demand for non-pharmacological solutions. Alternative therapies like acupuncture are gaining traction as patients seek comprehensive pain management solutions, indicating a shift toward more integrative treatment approaches.

Medication (Dominant) vs. Acupuncture (Emerging)

Medication remains a dominant force in the treatment of piriformis syndrome, primarily due to its immediate effectiveness in alleviating pain and discomfort. Common options include NSAIDs and stronger prescription medications tailored for acute pain relief. In contrast, acupuncture is seen as an emerging treatment option, appreciated for its holistic benefits and minimal side effects. It offers a complementary approach, often used alongside conventional medications to enhance overall therapeutic outcomes. Patients are increasingly exploring acupuncture as a viable alternative, particularly for chronic cases, contributing to its rising popularity within the US piriformis syndrome market.

### By Distribution Channel: E-Commerce (Largest) vs. Retail Pharmacies (Fastest-Growing)

The US piriformis syndrome market is witnessing a significant shift in the distribution channel segment, with E-Commerce leading in market share. This channel benefits from convenience and a wide range of products, which appeals to consumers looking for effective piriformis syndrome treatments. Meanwhile, Retail Pharmacies also play an essential role in the distribution of treatments, benefiting from local accessibility and trust among consumers. Both channels cater to a growing population seeking relief from symptoms, contributing to their respective positions in the market. Looking ahead, the growth trends within this segment are largely driven by increasing consumer preference for online shopping, which has accelerated post-pandemic. E-Commerce is expected to grow robustly, offering competitive pricing and a broader selection of products. Retail Pharmacies, while currently facing challenges from online competitors, are evolving by enhancing their offerings and services to attract patients. Collaborative initiatives with healthcare professionals may further support the growth of these distribution channels in the future.

E-Commerce (Dominant) vs. Retail Pharmacies (Emerging)

E-Commerce represents a dominant force in the US piriformis syndrome market, leveraging advanced technologies and logistics to reach consumers directly. It offers a variety of treatment options, enabling patients to easily compare products and choose effective solutions from the comfort of their homes. This channel particularly excels in marketing targeted towards specific demographics seeking both advice and products for symptom relief. On the other hand, Retail Pharmacies are emerging as vital entities by focusing on personalized services and immediate access to treatments. They foster relationships with patients through consultations and support, which traditional online platforms may lack. As both segments adapt to changing market dynamics, the interplay between E-Commerce and retail pharmacies will shape the future landscape of treatment availability and consumer preference.

### By End-User: Hospitals & Clinics (Largest) vs. Diagnostic Centers (Fastest-Growing)

In the US piriformis syndrome market, the distribution of end-user segments shows that hospitals and clinics hold the largest share, serving as the primary care providers for patients. They are equipped with the necessary resources and specialists to diagnose and treat piriformis syndrome, making them a critical component of patient care. While hospitals and clinics dominate the market, diagnostic centers are emerging as the fastest-growing segment. Their specialized focus on medical imaging and diagnostic procedures provides patients with quicker and more accurate diagnoses. This trend is driven by the increasing incidence of piriformis syndrome and the need for effective early identification, pushing more patients towards these facilities for evaluation and treatment options.

Hospitals & Clinics (Dominant) vs. Diagnostic Centers (Emerging)

Hospitals and clinics are the dominant players in the US piriformis syndrome market, offering comprehensive care that includes diagnosis, treatment, and rehabilitation services. They benefit from established infrastructures and a wide range of medical professionals specializing in musculoskeletal disorders. On the other hand, diagnostic centers represent an emerging segment that is gaining traction due to advancements in imaging technology and a growing awareness of the syndrome. These centers focus on precise diagnostics and often serve as a referral point for further treatment, thus playing a crucial role in the overall patient management continuum.

## Competitive Benchmarking

The piriformis syndrome market exhibits a competitive landscape characterized by a blend of innovation, strategic partnerships, and a focus on patient-centric solutions. Key players such as Medtronic (US), Johnson & Johnson (US), and Stryker (US) are actively shaping the market dynamics through their operational strategies. Medtronic (US) emphasizes technological advancements in pain management devices, while Johnson & Johnson (US) focuses on expanding its portfolio through acquisitions and partnerships aimed at enhancing treatment options. Stryker (US) is known for its commitment to innovation in surgical instruments and rehabilitation technologies, which collectively contribute to a competitive environment that prioritizes advanced therapeutic solutions and improved patient outcomes.In terms of business tactics, companies are increasingly localizing manufacturing to enhance supply chain efficiency and reduce operational costs. The market structure appears moderately fragmented, with several players vying for market share. This fragmentation is influenced by the diverse range of treatment options available, from surgical interventions to non-invasive therapies, allowing companies to cater to various patient needs and preferences. The collective influence of these key players fosters a dynamic competitive atmosphere, where innovation and operational efficiency are paramount.
In October Medtronic (US) announced the launch of a new line of neuromodulation devices specifically designed for chronic pain management, including piriformis syndrome. This strategic move is significant as it not only expands Medtronic's product offerings but also positions the company as a leader in addressing complex pain conditions through advanced technology. The introduction of these devices is expected to enhance patient outcomes and solidify Medtronic's market presence.
In September Johnson & Johnson (US) completed the acquisition of a promising biotech firm specializing in regenerative medicine for musculoskeletal disorders. This acquisition is pivotal as it aligns with Johnson & Johnson's strategy to diversify its treatment modalities for conditions like piriformis syndrome, potentially leading to innovative therapies that could reshape patient care. The integration of regenerative medicine into their portfolio may provide a competitive edge in the evolving landscape of pain management.
In August Stryker (US) unveiled a new robotic-assisted surgical system aimed at improving precision in procedures related to piriformis syndrome. This development underscores Stryker's commitment to leveraging technology to enhance surgical outcomes. The introduction of robotic assistance in surgeries not only improves efficiency but also reduces recovery times, thereby appealing to both healthcare providers and patients seeking effective treatment options.
As of November the competitive trends in the piriformis syndrome market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) in treatment protocols. Strategic alliances among key players are shaping the landscape, fostering innovation and collaborative approaches to patient care. Looking ahead, competitive differentiation is likely to evolve from traditional price-based strategies to a focus on technological innovation, enhanced patient experiences, and reliable supply chains. This shift indicates a growing recognition of the importance of quality and efficacy in treatment options, which may ultimately redefine market dynamics.

## Recent News & Developments

The US Piriformis Syndrome Market has seen notable developments in recent months, focusing on growth and innovation from key players such as Teleflex, Smith and Nephew, Amedica Corporation, and Medtronic. In particular, there's been increasing interest in minimally invasive procedures and advancements in treatment solutions aimed at alleviating the symptoms of piriformis syndrome. Current affairs highlight a rise in the market valuation of companies like Boston Scientific and Abbott Laboratories, reflecting their commitment to Research and Development, which is positively impacting patient outcomes.

In September 2023, Johnson and Johnson announced a strategic partnership with Aesculap to enhance the availability of their products targeted at treating musculoskeletal disorders, further solidifying their presence in this niche market. Moreover, the ongoing regulatory approvals for innovative devices and medications signify a robust growth trajectory. In the last couple of years, improvements in reimbursement policies for treatment options have played a crucial role in market expansion, driving competitive dynamics among companies like Stryker and NuVasive. Overall, the market's landscape is evolving, supported by technological advancements and strategic collaborations among leading entities.

## Report Scope

| MARKET SIZE 2024 | 0.06(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 0.06(USD Million) |
| MARKET SIZE 2035 | 0.114(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.63% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Medtronic (US), Johnson & Johnson (US), Stryker (US), Boston Scientific (US), Abbott Laboratories (US), Baxter International (US), Smith & Nephew (GB), Zimmer Biomet (US), NuVasive (US) |
| Segments Covered | Cause, Diagnostic Test, Treatment, Distribution Channel, End-User |
| Key Market Opportunities | Advancements in non-invasive treatment options enhance growth potential in the piriformis syndrome market. |
| Key Market Dynamics | Rising demand for innovative therapies drives competition and regulatory scrutiny in the piriformis syndrome market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the projected market valuation for the US piriformis syndrome market in 2035?**
A: The projected market valuation for the US piriformis syndrome market in 2035 is $0.114 Million.

**Q: What was the market valuation for the US piriformis syndrome market in 2024?**
A: The market valuation for the US piriformis syndrome market in 2024 was $0.06 Million.

**Q: What is the expected CAGR for the US piriformis syndrome market during the forecast period 2025 - 2035?**
A: The expected CAGR for the US piriformis syndrome market during the forecast period 2025 - 2035 is 6.63%.

**Q: Which companies are considered key players in the US piriformis syndrome market?**
A: Key players in the US piriformis syndrome market include Medtronic, Johnson & Johnson, Stryker, Boston Scientific, Abbott Laboratories, Baxter International, Smith & Nephew, Zimmer Biomet, and NuVasive.

**Q: What are the main causes of piriformis syndrome as per market segmentation?**
A: The main causes of piriformis syndrome include trauma, spasms, overuse injury, and others, with respective valuations in the range of $0.012 - $0.034 Million.

**Q: What diagnostic tests are utilized for piriformis syndrome, and what are their market valuations?**
A: Diagnostic tests for piriformis syndrome include MRI, CT, X-rays, neurophysiologic testing, EMG, Beatty test, FAIR test, and others, with valuations ranging from $0.003 to $0.028 Million.

**Q: What treatment options are available for piriformis syndrome, and how are they valued in the market?**
A: Treatment options for piriformis syndrome include medication, physical therapy, acupuncture, prolotherapy, OMT, surgery, and others, with total market valuation reaching $0.06 - $0.114 Million.

**Q: How is the distribution of piriformis syndrome treatments segmented in the market?**
A: The distribution of piriformis syndrome treatments is segmented into E-commerce, retail pharmacies, and others, with valuations between $0.006 and $0.068 Million.

**Q: What are the end-user segments for piriformis syndrome treatments?**
A: End-user segments for piriformis syndrome treatments include hospitals & clinics, diagnostic centers, and others, with valuations ranging from $0.012 to $0.057 Million.

**Q: What trends are anticipated in the US piriformis syndrome market by 2035?**
A: Trends anticipated in the US piriformis syndrome market by 2035 suggest a growing focus on advanced diagnostic and treatment options, driven by an increasing market valuation.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-piriformis-syndrome-market-20014*